-
Results of the RED-HF (Reduction of Events by Darbepoetin Alfa in Heart Failure) trial were presented at the ACC in San Francisco and published simultaneously in the New England Journal of Medicine.
FORBES: Yet Another Negative Trial For Amgen's Aranesp
-
But he said that the less-sick outpatient heart failure sufferers in this trial should not be used to draw conclusions about the safety of Natrecor for heart failure inpatients in hospital wards.
FORBES: Magazine Article
-
Another new drug, tolvaptan, from Japanese drug firm Otsuka, improved the symptoms of heart failure patients in a clinical trial presented at ACC.
FORBES: Magazine Article
-
Separately, Genvec has also been testing skeletal myoblast cell therapy in heart failure patients, recently completing a 28-patient-trial led by Arizona Heart Institute cardiologist Nabil Dib.
FORBES: Using Thigh Muscle To Fix The Heart
-
's clinical trial of a gene therapy in patients with advanced heart failure.
WSJ: The Future of Medicine Is Now: Medical Innovations
-
In a giant trial an implanted device sold by Medtronic slashed deaths from heart failure by 25% and reduced hospitalizations by a third.
FORBES: Magazine Article
-
Genzyme is itself involved in a European 300-patient phase II trial that attempts to use skeletal muscle cells from the leg to prevent heart failure.
FORBES: Small Stem Cells Find Big Backers
-
AtheroGenics saw the failure of its key trial of AGI-1067, a pill designed to prevent heart attacks and strokes, torpedo the chances of the drug being approved in the next year.
FORBES: Magazine Article
-
The experts described a very specific clinical trial that would put Natrecor through the ringer, comparing it to the standard of care in heart failure.
FORBES: Bitter Pill For J&J On Heart Drug